Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Glucose alters the symbiotic relationships between gut microbiota and host physiology

Glucose alters the symbiotic relationships between gut microbiota and host physiology Bacteria and mammals exhibit all aspects of symbiosis. Metabolic flux in bacteria and in specific host cells can influence host-microbe symbiotic relationships and tip the balance between mutualism, commensalism, and parasitism. The relationship between microbes and host metabolism is bidirectional: microbes can influence host blood glucose, but glucose levels can influence the microbiota and host response to specific bacteria. A key consideration determining symbiotic relationships is compartmentalization of bacterial niches by mucosal, chemical, and physical barriers of the gut. We propose that compartmentalization of glucose levels in the blood versus the intestinal lumen is another important factor dictating host-microbe symbiosis. Host glucose and specific bacteria can modify the intestinal barrier, immune function, and antimicrobial defenses, which can then break down compartmentalization of microbes, alter glucose levels and impact symbiosis. Determining how glucose metabolism promotes mutualistic, commensal, and parasitic relationships within the entire microbiota community is relevant to glucose control in diabetes and enteric infections, which occur more often and have worse outcomes in diabetics. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Endocrinology and Metabolism The American Physiological Society

Glucose alters the symbiotic relationships between gut microbiota and host physiology

Download PDF
6 pages

Loading next page...
 
/lp/the-american-physiological-society/glucose-alters-symbiotic-relationships-between-gut-microbiota-and-host-HZTsXjqjSB

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0193-1849
eISSN
1522-1555
DOI
10.1152/ajpendo.00485.2019
Publisher site
See Article on Publisher Site

Abstract

Bacteria and mammals exhibit all aspects of symbiosis. Metabolic flux in bacteria and in specific host cells can influence host-microbe symbiotic relationships and tip the balance between mutualism, commensalism, and parasitism. The relationship between microbes and host metabolism is bidirectional: microbes can influence host blood glucose, but glucose levels can influence the microbiota and host response to specific bacteria. A key consideration determining symbiotic relationships is compartmentalization of bacterial niches by mucosal, chemical, and physical barriers of the gut. We propose that compartmentalization of glucose levels in the blood versus the intestinal lumen is another important factor dictating host-microbe symbiosis. Host glucose and specific bacteria can modify the intestinal barrier, immune function, and antimicrobial defenses, which can then break down compartmentalization of microbes, alter glucose levels and impact symbiosis. Determining how glucose metabolism promotes mutualistic, commensal, and parasitic relationships within the entire microbiota community is relevant to glucose control in diabetes and enteric infections, which occur more often and have worse outcomes in diabetics.

Journal

AJP - Endocrinology and Metabolism – The American Physiological Society

Published: Feb 1, 2020

References

  • Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
    Amar, J; Chabo, C; Waget, A; Klopp, P; Vachoux, C; Bermúdez-Humarán, LG; Smirnova, N; Bergé, M; Sulpice, T; Lahtinen, S; Ouwehand, A; Langella, P; Rautonen, N; Sansonetti, PJ; Burcelin, R
  • A microbial protein that alleviates metabolic syndrome
    Anhê, FF; Marette, A
  • The gut microbiota as a mediator of metabolic benefits after bariatric surgery
    Anhê, FF; Varin, TV; Schertzer, JD; Marette, A
  • Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection
    Anwar, MA; Panneerselvam, S; Shah, M; Choi, S
  • Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
    Benfield, T; Jensen, JS; Nordestgaard, BG
  • TNF, but not hyperinsulinemia or hyperglycemia, is a key driver of obesity-induced monocytosis revealing that inflammatory monocytes correlate with insulin in obese male mice
    Breznik, JA; Naidoo, A; Foley, KP; Schulz, C; Lau, TC; Loukov, D; Sloboda, DM; Bowdish, DM; Schertzer, JD
  • Metabolic endotoxemia initiates obesity and insulin resistance
    Cani, PD; Amar, J; Iglesias, MA; Poggi, M; Knauf, C; Bastelica, D; Neyrinck, AM; Fava, F; Tuohy, KM; Chabo, C; Waget, A; Delmée, E; Cousin, B; Sulpice, T; Chamontin, B; Ferrières, J; Tanti, JF; Gibson, GR; Casteilla, L; Delzenne, NM; Alessi, MC; Burcelin, R
  • Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
    Cani, PD; Bibiloni, R; Knauf, C; Waget, A; Neyrinck, AM; Delzenne, NM; Burcelin, R
  • Targeting macrophage scavenger receptor 1 promotes insulin resistance in obese male mice
    Cavallari, JF; Anhê, FF; Foley, KP; Denou, E; Chan, RW; Bowdish, DME; Schertzer, JD
  • Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4
    Cavallari, JF; Fullerton, MD; Duggan, BM; Foley, KP; Denou, E; Smith, BK; Desjardins, EM; Henriksbo, BD; Kim, KJ; Tuinema, BR; Stearns, JC; Prescott, D; Rosenstiel, P; Coombes, BK; Steinberg, GR; Schertzer, JD
  • Intestinal microbiota contributes to energy balance, metabolic inflammation, and insulin resistance in obesity
    Cavallari, JF; Schertzer, JD
  • Circulating NOD1 activators and hematopoietic NOD1 contribute to metabolic inflammation and insulin resistance
    Chan, KL; Tam, TH; Boroumand, P; Prescott, D; Costford, SR; Escalante, NK; Fine, N; Tu, Y; Robertson, SJ; Prabaharan, D; Liu, Z; Bilan, PJ; Salter, MW; Glogauer, M; Girardin, SE; Philpott, DJ; Klip, A
  • Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1
    Chi, W; Dao, D; Lau, TC; Henriksbo, BD; Cavallari, JF; Foley, KP; Schertzer, JD
  • Total lipopolysaccharide from the human gut microbiome silences Toll-like receptor signaling
    d’Hennezel, E; Abubucker, S; Murphy, LO; Cullen, TW
  • Critical advances in septicemia and septic shock
    Das, UN
  • Diet rapidly and reproducibly alters the human gut microbiome
    David, LA; Maurice, CF; Carmody, RN; Gootenberg, DB; Button, JE; Wolfe, BE; Ling, AV; Devlin, AS; Varma, Y; Fischbach, MA; Biddinger, SB; Dutton, RJ; Turnbaugh, PJ
  • Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance
    Denou, E; Lolmède, K; Garidou, L; Pomie, C; Chabo, C; Lau, TC; Fullerton, MD; Nigro, G; Zakaroff-Girard, A; Luche, E; Garret, C; Serino, M; Amar, J; Courtney, M; Cavallari, JF; Henriksbo, BD; Barra, NG; Foley, KP; McPhee, JB; Duggan, BM; O’Neill, HM; Lee, AJ; Sansonetti, P; Ashkar, AA; Khan, WI; Surette, MG; Bouloumié, A; Steinberg, GR; Burcelin, R; Schertzer, JD
  • High-intensity exercise training increases the diversity and metabolic capacity of the mouse distal gut microbiota during diet-induced obesity
    Denou, E; Marcinko, K; Surette, MG; Steinberg, GR; Schertzer, JD
  • Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
    Depommier, C; Everard, A; Druart, C; Plovier, H; Van Hul, M; Vieira-Silva, S; Falony, G; Raes, J; Maiter, D; Delzenne, NM; de Barsy, M; Loumaye, A; Hermans, MP; Thissen, JP; de Vos, WM; Cani, PD
  • Long term but not short term exposure to obesity related microbiota promotes host insulin resistance
    Foley, KP; Zlitni, S; Denou, E; Duggan, BM; Chan, RW; Stearns, JC; Schertzer, JD
  • The short-chain fatty acid acetate in body weight control and insulin sensitivity
    Hernández, MA; Canfora, EE; Jocken, JW; Blaak, EE
  • Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes–a pilot study
    Gosiewski, T; Salamon, D; Szopa, M; Sroka, A; Malecki, MT; Bulanda, M
  • Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine
    Jones, SA; Jorgensen, M; Chowdhury, FZ; Rodgers, R; Hartline, J; Leatham, MP; Struve, C; Krogfelt, KA; Cohen, PS; Conway, T
  • Mice with streptozotocin-induced hyperglycemia are susceptible to invasive enteric bacterial infection
    Koley, H; Ghosh, P; Sinha, R; Mitra, S; Mukherjee, P; Howlader, DR; Chaki, C; Nag, D
  • Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
    Larsen, N; Vogensen, FK; van den Berg, FW; Nielsen, DS; Andreasen, AS; Pedersen, BK; Al-Soud, WA; Sørensen, SJ; Hansen, LH; Jakobsen, M
  • Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis
    Lelouvier, B; Servant, F; Païssé, S; Brunet, AC; Benyahya, S; Serino, M; Valle, C; Ortiz, MR; Puig, J; Courtney, M; Federici, M; Fernández-Real, JM; Burcelin, R; Amar, J
  • Short-chain fatty acids: bacterial messengers modulating the immunometabolism of T cells
    Luu, M; Visekruna, A
  • The impact of dietary fiber on gut microbiota in host health and disease
    Makki, K; Deehan, EC; Walter, J; Bäckhed, F
  • Glucose metabolism by Escherichia coli inhibits vibrio cholerae intestinal colonization of zebrafish
    Nag, D; Breen, P; Raychaudhuri, S; Withey, JH
  • Human gut microbes impact host serum metabolome and insulin sensitivity
    Pedersen, HK; Gudmundsdottir, V; Nielsen, HB; Hyotylainen, T; Nielsen, T; Jensen, BA; Forslund, K; Hildebrand, F; Prifti, E; Falony, G; Le Chatelier, E; Levenez, F; Doré, J; Mattila, I; Plichta, DR; Pöhö, P; Hellgren, LI; Arumugam, M; Sunagawa, S; Vieira-Silva, S; Jørgensen, T; Holm, JB; Trošt, K; Kristiansen, K; Brix, S; Raes, J; Wang, J; Hansen, T; Bork, P; Brunak, S; Oresic, M; Ehrlich, SD; Pedersen, O
  • Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness
    Pickard, JM; Maurice, CF; Kinnebrew, MA; Abt, MC; Schenten, D; Golovkina, TV; Bogatyrev, SR; Ismagilov, RF; Pamer, EG; Turnbaugh, PJ; Chervonsky, AV
  • C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet
    Poggi, M; Bastelica, D; Gual, P; Iglesias, MA; Gremeaux, T; Knauf, C; Peiretti, F; Verdier, M; Juhan-Vague, I; Tanti, JF; Burcelin, R; Alessi, MC
  • Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
    Pomié, C; Blasco-Baque, V; Klopp, P; Nicolas, S; Waget, A; Loubières, P; Azalbert, V; Puel, A; Lopez, F; Dray, C; Valet, P; Lelouvier, B; Servant, F; Courtney, M; Amar, J; Burcelin, R; Garidou, L
  • Role of short chain fatty acid receptors in intestinal physiology and pathophysiology
    Priyadarshini, M; Kotlo, KU; Dudeja, PK; Layden, BT
  • Pathogen-mediated inhibition of anorexia promotes host survival and transmission
    Rao, S; Schieber, AMP; O’Connor, CP; Leblanc, M; Michel, D; Ayres, JS
  • Cooperative metabolic adaptations in the host can favor asymptomatic infection and select for attenuated virulence in an enteric pathogen
    Sanchez, KK; Chen, GY; Schieber, AM; Redford, SE; Shokhirev, MN; Leblanc, M; Lee, YM; Ayres, JS
  • NOD1 activators link innate immunity to insulin resistance
    Schertzer, JD; Tamrakar, AK; Magalhães, JG; Pereira, S; Bilan, PJ; Fullerton, MD; Liu, Z; Steinberg, GR; Giacca, A; Philpott, DJ; Klip, A
  • Cross feeding of glucose metabolism byproducts of Escherichia coli human gut isolates and probiotic strains affect survival of Vibrio cholerae
    Sengupta, C; Ekka, M; Arora, S; Dhaware, PD; Chowdhury, R; Raychaudhuri, S
  • Diabetes mellitus, fasting glucose, and risk of cause-specific death
    Rao Kondapally Seshasai, S; Kaptoge, S; Thompson, A; Di Angelantonio, E; Gao, P; Sarwar, N; Whincup, PH; Mukamal, KJ; Gillum, RF; Holme, I; Njølstad, I; Fletcher, A; Nilsson, P; Lewington, S; Collins, R; Gudnason, V; Thompson, SG; Sattar, N; Selvin, E; Hu, FB; Danesh, J
  • Active transport of phosphorylated carbohydrates promotes intestinal colonization and transmission of a bacterial pathogen
    Sit, B; Crowley, SM; Bhullar, K; Lai, CC; Tang, C; Hooda, Y; Calmettes, C; Khambati, H; Ma, C; Brumell, JH; Schryvers, AB; Vallance, BA; Moraes, TF
  • Diabetes mellitus–a newly described risk factor for infection from Salmonella enteritidis
    Telzak, EE; Greenberg, MS; Budnick, LD; Singh, T; Blum, S
  • Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
    Thaiss, CA; Levy, M; Grosheva, I; Zheng, D; Soffer, E; Blacher, E; Braverman, S; Tengeler, AC; Barak, O; Elazar, M; Ben-Zeev, R; Lehavi-Regev, D; Katz, MN; Pevsner-Fischer, M; Gertler, A; Halpern, Z; Harmelin, A; Aamar, S; Serradas, P; Grosfeld, A; Shapiro, H; Geiger, B; Elinav, E
  • The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
    Vandanmagsar, B; Youm, YH; Ravussin, A; Galgani, JE; Stadler, K; Mynatt, RL; Ravussin, E; Stephens, JM; Dixit, VD
  • The Intestinal Immune System in Obesity and Insulin Resistance
    Winer, DA; Luck, H; Tsai, S; Winer, S
  • Immunologic impact of the intestine in metabolic disease
    Winer, DA; Winer, S; Dranse, HJ; Lam, TK
  • Molecular characterisation of the faecal microbiota in patients with type II diabetes
    Wu, X; Ma, C; Han, L; Nawaz, M; Gao, F; Zhang, X; Yu, P; Zhao, C; Li, L; Zhou, A; Wang, J; Moore, JE; Millar, BC; Xu, J
  • A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome
    Xiao, S; Fei, N; Pang, X; Shen, J; Wang, L; Zhang, B; Zhang, M; Zhang, X; Zhang, C; Li, M; Sun, L; Xue, Z; Wang, J; Feng, J; Yan, F; Zhao, N; Liu, J; Long, W; Zhao, L
  • Association of bactericidal dysfunction of paneth cells in streptozocin-induced diabetic mice with insulin deficiency
    Yu, T; Yang, HS; Lu, XJ; Xia, ZS; Ouyang, H; Shan, TD; Huang, CZ; Chen, QK
  • Personalized nutrition by prediction of glycemic responses
    Zeevi, D; Korem, T; Zmora, N; Israeli, D; Rothschild, D; Weinberger, A; Ben-Yacov, O; Lador, D; Avnit-Sagi, T; Lotan-Pompan, M; Suez, J; Mahdi, JA; Matot, E; Malka, G; Kosower, N; Rein, M; Zilberman-Schapira, G; Dohnalová, L; Pevsner-Fischer, M; Bikovsky, R; Halpern, Z; Elinav, E; Segal, E
  • Sodium butyrate improves liver glycogen metabolism in type 2 diabetes mellitus
    Zhang, WQ; Zhao, TT; Gui, DK; Gao, CL; Gu, JL; Gan, WJ; Huang, W; Xu, Y; Zhou, H; Chen, WN; Liu, ZL; Xu, YH
  • Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
    Zhao, L; Zhang, F; Ding, X; Wu, G; Lam, YY; Wang, X; Fu, H; Xue, X; Lu, C; Ma, J; Yu, L; Xu, C; Ren, Z; Xu, Y; Xu, S; Shen, H; Zhu, X; Shi, Y; Shen, Q; Dong, W; Liu, R; Ling, Y; Zeng, Y; Wang, X; Zhang, Q; Wang, J; Wang, L; Wu, Y; Zeng, B; Wei, H; Zhang, M; Peng, Y; Zhang, C